Facts
The French Basketball Federation (Fédération Française de Basket-Ball, FFBB) charges respondent M37 or a violation of the Anti-Doping Rules. During a match on September 28, 2007, a sample was taken for doping test purposes. The analysis of the sample showed the presence of a metabolite of methylphenidate which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.
History
The respondent had mentioned on the doping control form the use of a pharmaceutical product containing the prohibited substance. He had no intention to enhance his sport performance. His psychiatrist explained he used this medication because of the attention disorder and hyperactivity since childhood and to stabilize a chronic depression. However he didn't produce a medical report for his condition or prescription for this medication.
Decision
1. The sanction is a period of ineligibility of three months, in which respondent can't take part in competition or manifestations organized or authorized by the FFBB.
2. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.
